Scientific Meeting 2026
Scientific Meeting
The Melanoma and Skin Cancer Trials 2026 Scientific Meeting will bring together Australian leaders in melanoma and skin cancer clinical trials to share the latest discoveries and foster further innovative research.
This page will be updated as planning progresses.
Details
Date: Wednesday, 18 November 2026
Location: Melbourne, Australia
Contact
Gabrielle Byars
E: gabrielle.byars@masc.org.au
Who should attend?
The 2026 Melanoma and Skin Cancer Trials Scientific Meeting is relevant to those who represent the many disciplines critical to our work including:
Oncologists
Surgeons
Radiation specialists
Nurses
Dermatologists
Allied health professionals
Health economists
Epidemiologists
Statisticians
Ophthalmologists
Research scientists
Pathologists
Clinical trial coordinators
Data managers
Consumers / patient advocates and their families
Meeting Convenor
Prof Mark Shackelton is Chair of the Melanoma and Skin Cancer Trials Board of Directors. He is also Director of Oncology at Alfred Health, Co-Director of Monash Partners Comprehensive Cancer Consortium, Professor of Oncology at Monash University, Director of Cancer Trials Australia, and a Victorian Cancer Agency Clinical Research Fellow. After training in medical oncology in Melbourne, he undertook PhD studies at the Walter and Eliza Hall Institute and post-doctoral work at the University of Michigan, receiving several major prizes including the 2012 Australian Science Minister’s Prize for Life Scientist of the Year.
MASC Trials 2024 Scientific Meeting
Speakers
The program will feature keynote speakers and a stellar line-up of leaders in their field who will discuss the latest clinical research in melanoma and skin cancer. Updates on Melanoma and Skin Cancer Trials’ research portfolio and opportunities for new research collaborations will form part of the meeting. Consumer presentations will also provide a unique perspective on our patient engagement.
More speakers and their details will be added to this webpage as planning progresses.
Keynote speakers
Speaker
Talk:
Session
Session chair:
Speakers
Speaker
Talk:
Sponsors
Platinum Sponsor
Gold Sponsor
Silver Sponsors
Sponsorship opportunities available
Melanoma and Skin Cancer Trials offers a range of benefits to sponsors of its Annual Scientific Meeting. If your company is interested in sponsoring this event, please email hello@masc.org.au for further details.
Melanoma and Skin Cancer Trials Scientific Meeting 2026 organising committee
- Prof Mark Shackleton, Board Chair of Melanoma and Skin Cancer Trials, Director of Oncology at Alfred Health, Professor of Oncology at Monash University, and Director of Cancer Trials Australia
- Alison Button-Sloan, Chair, Melanoma and Skin Cancer Trials Consumer Advisory Panel
- Gabrielle Byars, CEO, Melanoma and Skin Cancer Trials